Jounce Therapeutics Announces Update on Vopratelimab Program
November 02, 2020 07:00 ET
|
Jounce Therapeutics, Inc.
- No further enrollment in EMERGE trial of vopratelimab in combination with ipilimumab based on interim analysis- - First patient dosed in SELECT trial of vopratelimab in combination with JTX-4014 in...
Outlook on the High Purity Quartz Sand for UVC Lighting Global Market to 2030 - Key Industry Developments
September 25, 2020 05:39 ET
|
Research and Markets
Dublin, Sept. 25, 2020 (GLOBE NEWSWIRE) -- The "High Purity Quartz Sand Market for UVC Lighting - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2030" report has been...
Jounce Therapeutics Reports Second Quarter 2020 Financial Results
August 07, 2020 06:30 ET
|
Jounce Therapeutics, Inc.
- Completed enrollment of Phase 2 EMERGE trial for the interim analysis of efficacy and biomarker data in early 2021 - - On track to initiate Phase 2 SELECT trial and Phase 1 trial for JTX-8064 in...
Jounce Therapeutics Reports Fourth Quarter and Full Year 2019 Financial Results
February 27, 2020 06:30 ET
|
Jounce Therapeutics, Inc.
- On track to initiate Phase 2 SELECT trial in mid-2020 and present preliminary efficacy and related biomarker data from Phase 2 EMERGE trial in 2H 2020 - - Ended 2019 with $170.4 million in...
Jounce Therapeutics Presents New Vopratelimab Predictive Biomarker Data Supporting Use in the Upcoming SELECT Trial at the 2020 ASCO-SITC Clinical Immuno-Oncology Symposium Annual Meeting and Announces Research Collaboration with NanoString Technologies
February 06, 2020 08:00 ET
|
Jounce Therapeutics, Inc.
- Identification of a predictive biomarker – based on an 18 gene RNA signature and vopratelimab-specific threshold (TISvopra) – for the emergence of ICOS hi CD4 T cells that predicted clinical benefit...
Select Sands Concerned Shareholders Seek To Elect a New Board
August 08, 2019 09:00 ET
|
Select Sands Corp.
VANCOUVER, British Columbia, Aug. 08, 2019 (GLOBE NEWSWIRE) -- A group of shareholders of Select Sands Corp. (“Select Sands” or the “Company”) (TSXV: SNS | OTCQB: SLSDF) led by John LaGourgue (the...
Select Sands Reports Results for the Third Quarter 2018
November 14, 2018 16:10 ET
|
Select Sands Corp.
VANCOUVER, British Columbia, Nov. 14, 2018 (GLOBE NEWSWIRE) -- Select Sands Corp. (“Select Sands” or the “Company”) (TSXV: SNS, OTC: SLSDF) today announced operational and financial results for Q3...
Select Sands to Release Q3 2018 Earnings on November 14 and Host Conference Call on November 15
November 09, 2018 08:30 ET
|
Select Sands Corp.
VANCOUVER, British Columbia, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Select Sands Corp. ("Select Sands" or the "Company") (TSXV: SNS | OTCQX: SLSDF) will release financial and operational results for the...
Select Sands Sells 80,000 Tons of Frac and Industrial Sands in Q3 2018
October 25, 2018 08:30 ET
|
Select Sands Corp.
Company continues production and sales, remains well capitalized with $5M USD cash, with an additional $5M USD undrawn line of credit available VANCOUVER, B.C., Oct. 25, 2018 (GLOBE NEWSWIRE) --...
Select Sands Announces Temporary Furlough at Sandtown
October 15, 2018 08:33 ET
|
Select Sands Corp.
VANCOUVER, B.C., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Select Sands Corp. ("Select Sands" or the "Company") (TSXV: SNS | OTCQX: SLSDF) announced today that it has placed 26 employees at its Arkansas...